Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis

The established biomarker for hepatocellular carcinoma (HCC), serum α-fetoprotein (AFP), has suboptimal performance in early disease stages. This study aimed to develop a metabolite panel to differentiate early-stage HCC from cirrhosis. Cross-sectional metabolomic analyses of serum samples were perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Da Jung, Cho, Eun Ju, Yu, Kyung-Sang, Jang, In-Jin, Yoon, Jung-Hwan, Park, Taesung, Cho, Joo-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826937/
https://www.ncbi.nlm.nih.gov/pubmed/31590436
http://dx.doi.org/10.3390/cancers11101497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826937/
https://www.ncbi.nlm.nih.gov/pubmed/31590436
http://dx.doi.org/10.3390/cancers11101497

Ejemplares similares